mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma

Efficient vaccination can be achieved by injections of in vitro transcribed mRNA (ivt mRNA) coding for antigens. This vaccine format is particularly versatile and allows the production of individualised vaccines conferring, T-cell immunity against specific cancer mutations. The CDR3 hypervariable re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tusup, Marina, Läuchli, Severin, Jarzebska, Natalia Teresa, French, Lars E., Chang, Yun-Tsan, Vonow-Eisenring, Maya, Su, Andreas, Kündig, Thomas M., Guenova, Emmanuella, Pascolo, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308944/
https://www.ncbi.nlm.nih.gov/pubmed/34371731
http://dx.doi.org/10.3390/pharmaceutics13071040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308944/
https://www.ncbi.nlm.nih.gov/pubmed/34371731
http://dx.doi.org/10.3390/pharmaceutics13071040

Ejemplares similares